SIGNIFICANT IMPACT OF THE -C(93)T-POLYMORPHISM IN THE APOLIPOPROTEIN(A) GENE ON LP(A) CONCENTRATIONS IN AFRICANS BUT NOT IN CAUCASIANS - CONFOUNDING EFFECT OF LINKAGE DISEQUILIBRIUM/
Hg. Kraft et al., SIGNIFICANT IMPACT OF THE -C(93)T-POLYMORPHISM IN THE APOLIPOPROTEIN(A) GENE ON LP(A) CONCENTRATIONS IN AFRICANS BUT NOT IN CAUCASIANS - CONFOUNDING EFFECT OF LINKAGE DISEQUILIBRIUM/, Human molecular genetics, 7(2), 1998, pp. 257-264
Lipoprotein(a) [Lp(a)] is a quantitative genetic trait in human plasma
associated with atherothrombotic disease, The major determinant of Lp
(a) concentration is the apolipoprotein(a) [apo(a)] gene locus, Variat
ion in the number of kringle IV repeats (K-IV VNTR) in apo(a) has a di
rect effect on Lp(a) concentrations but explains only a fraction of th
e large intra-and interpopulation variance in Lp(a) levels, Effects on
Lp(a) of other intragenic polymorphisms including a pentanucleotide r
epeat (PNRP) in the promoter likely reflect allelic associations with
as yet unidentified sequence variation in the apo(a) gene, We have stu
died a candidate C-->T transition in two European and two African popu
lations, This polymorphism in the 5' region of the apo(a) gene creates
an ATG start codon thereby reducing apo(a) translation in vitro by 60
%. All samples were also analyzed for the K-IV VNTR and the PNRP to st
ratify for their effects and to consider allelic associations, Consist
ent with the in vitro effect the C-->T transition was associated with
a significant reduction in Lp(a) levels in both African populations (P
< 0.0056), In Caucasians, however, the effect was not significant, Thi
s was explained by linkage disequilibrium of the +93 T with apo(a) all
eles of intermediate length (K-24-K-34) and with nine PNRs, In Europea
ns these alleles are associated with low Lp(a) which makes any potenti
al effect of the +93 T undetectable in the total sample. From our resu
lts we conclude (i) that the +93 C/T polymorphism is the second known
intragenic apo(a) polymorphism which affects Lp(a) levels directly in
vivo; (ii) that allelic associations may mask the effect of a mutation
; and (iii) that heterogeneity of an effect of a mutation across popul
ations does not disprove causality.